{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:11Z","timestamp":1786994411458,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.msard.2025.106386","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T02:42:19Z","timestamp":1742092939000},"page":"106386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Medication use is associated with cognitive deficits in people with multiple sclerosis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0598-1470","authenticated-orcid":false,"given":"C.","family":"Atiyeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gilmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"das Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106386_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104476","article-title":"The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis: running head: OAB-V8, BICAMS and HAD scale in MS","volume":"70","author":"Akko\u00e7","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2025.106386_bib0002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/gps.4507","article-title":"Anticholinergic effect on cognition (AEC) of drugs commonly used in older people","volume":"32","author":"Bishara","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.msard.2025.106386_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102770","article-title":"Does cognitive training improve attention\/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program","volume":"49","author":"Blair","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"14","key":"10.1016\/j.msard.2025.106386_bib0004","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study","volume":"169","author":"Carri\u00e8re","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.msard.2025.106386_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11910-023-01289-9","article-title":"Polypharmacy in Multiple sclerosis: prevalence, risks, and mitigation strategies","volume":"23","author":"Chapman","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/13524585221122207","article-title":"Polypharmacy and multiple sclerosis: a population-based study","volume":"29","author":"Chertcoff","year":"2023","journal-title":"Mult. Scler. Houndmills Basingstoke Engl"},{"issue":"12","key":"10.1016\/j.msard.2025.106386_bib0007","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106386_bib0008","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.msard.2012.05.002","article-title":"Cognitive impact of anticholinergic medication in MS: adding insult to injury?","volume":"1","author":"Cruce","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106386_bib0009","unstructured":"DAGitty v3.1. Available from: https:\/\/www.dagitty.net\/dags.html [cited 2024 Jan 8]."},{"issue":"3","key":"10.1016\/j.msard.2025.106386_bib0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jnp.12283","article-title":"Investigating the association of mood and fatigue with objective and subjective cognitive impairment in multiple sclerosis","volume":"16","author":"Davenport","year":"2022","journal-title":"J. Neuropsychol."},{"issue":"3","key":"10.1016\/j.msard.2025.106386_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMa Intern. Med."},{"key":"10.1016\/j.msard.2025.106386_bib0012","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jns.2017.07.047","article-title":"Depression and fatigue in patients with multiple sclerosis","volume":"380","author":"Greeke","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106386_bib0013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fneur.2012.00074","article-title":"Cognitive dysfunction in multiple sclerosis","volume":"3","author":"Guimar\u00e3es","year":"2012","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106386_bib0014","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/17512433.2018.1528145","article-title":"Calculating and using the drug burden index score in research and practice","volume":"11","author":"Hilmer","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.msard.2025.106386_bib0015","unstructured":"Huebner J.M. Cognition, Fatigue, and Health-Related Quality of Life in Multiple Sclerosis: Exploring the Role of Polypharmacy and Anticholinergic Medication Burden, Dissertation, University of Missouri - Kansas City, 2022."},{"issue":"2","key":"10.1016\/j.msard.2025.106386_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/01.WNL.0000129828.03714.90","article-title":"Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS","volume":"63","author":"Huijbregts","year":"2004","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.msard.2025.106386_bib0017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/1352458503ms930oa","article-title":"Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis","volume":"1;9","author":"Janssens","year":"2003","journal-title":"Mult. Scler. J."},{"issue":"8","key":"10.1016\/j.msard.2025.106386_bib0018","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1179\/1743132815Y.0000000036","article-title":"Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability","volume":"37","author":"Jelinek","year":"2015","journal-title":"Neurol. Res."},{"issue":"2","key":"10.1016\/j.msard.2025.106386_bib0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ncl.2010.12.003","article-title":"Cognitive functioning in multiple sclerosis","volume":"29","author":"Julian","year":"2011","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7224\/1537-2073.2012-019","article-title":"Psychometric properties of the modified fatigue impact scale","volume":"15","author":"Larson","year":"2013","journal-title":"Int. J. MS. Care"},{"issue":"2","key":"10.1016\/j.msard.2025.106386_bib0021","first-page":"131","article-title":"The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients - the role of depression","volume":"7","author":"Maor","year":"2001","journal-title":"Mult. Scler. Clin. Lab. Res"},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0022","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC. Geriatr."},{"key":"10.1016\/j.msard.2025.106386_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103393","article-title":"Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests","author":"Merlo","year":"2022","journal-title":"Mult. Scler. Relat. Disord. [Internet]"},{"issue":"5","key":"10.1016\/j.msard.2025.106386_bib0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.acn.2006.06.008","article-title":"The relationship between perceived and objective cognitive functioning in multiple sclerosis","volume":"21","author":"Middleton","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.msard.2025.106386_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2017.11.028","article-title":"Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis","volume":"385","author":"Morrow","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106386_bib0026","unstructured":"Neuroms. Available from: https:\/\/neuroms.org\/ [cited 2023 Dec 11]."},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1682\/JRRD.2004.11.0148","article-title":"Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity","volume":"43","author":"Oken","year":"2006","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.msard.2025.106386_bib0028","article-title":"Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression","author":"Samartzis","year":"2014","journal-title":"Rehabil. Res. Pract."},{"key":"10.1016\/j.msard.2025.106386_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102950","article-title":"The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: lexical access speed, memory, and information processing speed independently contribute to SDMT performance","volume":"51","author":"Sandry","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.msard.2025.106386_bib0030","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.apmr.2013.05.009","article-title":"Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?","volume":"94","author":"Schwartz","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.msard.2025.106386_bib0031","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fneur.2020.00247","article-title":"Subjective cognitive decline and related cognitive deficits","volume":"11","author":"Si","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106386_bib0032","first-page":"99","article-title":"A survey of Multiple sclerosis. Part I perceived cognitive problems and compensatory strategy used","volume":"4","author":"Sullivan","year":"1990","journal-title":"Canad. J. Rehabilit."},{"issue":"3","key":"10.1016\/j.msard.2025.106386_bib0033","first-page":"239","article-title":"Polypharmacy in Multiple sclerosis: current knowledge and future directions","volume":"118","author":"Thelen","year":"2021","journal-title":"Mo Med."},{"issue":"5","key":"10.1016\/j.msard.2025.106386_bib0034","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpsychores.2014.02.013","article-title":"Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance","volume":"76","author":"Thelen","year":"2014","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0036","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40814-022-01073-5","article-title":"Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial","volume":"8","author":"Topcu","year":"2022","journal-title":"Pilot. Feasibility. Stud."},{"key":"10.1016\/j.msard.2025.106386_bib0037","unstructured":"UK Multiple Sclerosis Register. https:\/\/popdatasci.swan.ac.uk\/centres-of-excellence\/uk-multiple-sclerosis-register\/ [cited 2024 Jan 2]."},{"issue":"5","key":"10.1016\/j.msard.2025.106386_bib0039","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1037\/0022-006X.51.5.730","article-title":"The structure of psychological distress and well-being in general populations","volume":"51","author":"Veit","year":"1983","journal-title":"J. Consult. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.msard.2025.106386_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/acps.13435","article-title":"Determinants and consequences of polypharmacy in patients with a depressive disorder in later life","volume":"146","author":"Wiersema","year":"2022","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T08:26:04Z","timestamp":1746606364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825001282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S2211034825001282"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106386","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication use is associated with cognitive deficits in people with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106386"}}